BIOMETRX; INC. NEW COMMON STOC (OTCBB: BTRX)

View Portfolio
Back to Investopedia
Back to Investopedia




$0.17 0.00 (0.00%)
Real-time 12:00:00 AM ET
 Turn On
KEY STATS
52-Week High Price
1.50
52-Week Low Price
0.00
Avg Volume (3 Mo.)
0.00 M
Market Cap
0.00 B
P/E Ratio (TTM)
0.0
Diluted EPS (TTM)
0.00
Shares
0.23 M
Dividend Rate ($) / (%)
0.00/0.00
50%
50%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : N/A
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
SIMPSON MANUFACTURING;... (SSD) $23.71 -  $0.65(2.82%)1.10 B
EASTERN CO THE (EML) $11.59 -  $0.47(4.23%)0.07 B
L.S.STARRETT CO THE (SCX) $9.74 -  $0.06(0.61%)0.06 B
GABIREL TECHNOLOGIES (GWLK) $0.20 -  $0.04(16.67%)0.01 B
As of February 09, 2010 at 5:45 PM ET
STOCK ANALYSIS
There are currently no Stock Analysis.
BTRX RELATED HEADLINES
arrow
Stiefel Laboratories, Inc. Successfully Completes Tender Offer for Shares of Barrier Therapeutics, Inc.

Forbes.com 8/5/2008
arrow
Stiefel Laboratories, Inc. Successfully Completes Tender Offer for Shares of Barrier Therapeutics, Inc.
Stiefel Laboratories, Inc. Successfully Completes Tender Offer for Shares of Barrier Therapeutics, Inc.
by Prime Newswire 8/5/2008
arrow
Stiefel Laboratories, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to its Proposal to Acquire Barrier Therapeutics, Inc.

Forbes.com 7/29/2008
arrow
Barrier Therapeutics, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to the Stiefel Laboratories, Inc. Proposal to Acquire Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to the Stiefel Laboratories, Inc. Proposal to Acquire Barrier Therapeutics, Inc.
by Prime Newswire 7/29/2008
arrow
Stiefel Laboratories, Inc. Commences Tender Offer to Acquire Barrier Therapeutics, Inc.

Forbes.com 7/8/2008
arrow
Stiefel Laboratories Wraps Up Barrier
A privately-owned dermatology company acquires the smaller company to expand its products.
Forbes.com 6/23/2008
View All Headlines
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM2